SCHEMBL17516289

SCHEMBL17516289

CC(C)(C)N1CC2(CN(c3ccccn3)C2)C1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 17/20 0.58
▸ HSD17B10 Q99714 17/20 0.58
▸ HPGD P15428 12/20 0.58
▸ CYP1A2 P05177 5/20 0.58
▸ TSHR P16473 8/20 0.54
▸ USP2 O75604 4/20 0.54
▸ HIF1A Q16665 2/20 0.54
▸ CYP3A4 P08684 10/20 0.50
▸ CYP2D6 P10635 8/20 0.50
▸ CYP2C19 P33261 5/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ CYP2C9 P11712 3/20 0.48
▸ MAPK1 P28482 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ PLD1 Q13393 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11947826 0.83 HSD17B10 (0.57) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL17518848 0.82 ALDH1A1 (0.65) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL30556672 0.80 ALDH1A1 (0.77) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL11947809 0.80 HSD17B10 (0.64) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL136881 0.79 PLD1 (0.56) ALDH1A1HSD17B10SMN1; SMN2PLD1
SCHEMBL24435218 0.77 ALDH1A1 (0.73) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL26049676 0.77 ALDH1A1 (0.57) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL19558107 0.77 ALDH1A1 (0.58) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL30212352 0.76 ALDH1A1 (0.61) ALDH1A1HSD17B10HPGDCYP1A2TSHR
SCHEMBL25561240 0.76 ALDH1A1 (0.61) ALDH1A1HSD17B10HPGDCYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809545-B2 Factor XIa inhibitors MERCK SHARP & DOHME CORP. (US) 2017-11-07 — — US disclosed
US-20160046581-A1 Factor XIa Inhibitors MERCK SHARP & DOHME CORP. (US) 2016-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046581-A1 Factor XIa Inhibitors F11, F12, TFPI ALDH1A1 2920/4885HSD17B10 1681/4885HPGD 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback